StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.41+0.01 (+2.18%)

Close on Nov 18, 2026Market cap $82.86MP/E –Yield –

Lucid Diagnostics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Lucid Diagnostics's operating income for the twelve months ending Jun 30, 2026 was -$50.69M. For fiscal 2025 it was -$49.64M. The highest annual figure on record is -$8.28M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$49.64M–
FY2024Dec 31, 2024-$46.05M–
FY2023Dec 31, 2023-$48.48M–
FY2022Dec 31, 2022-$56.25M–
FY2021Dec 31, 2021-$27.42M–
FY2020Dec 31, 2020-$8.28M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.80M–
Q1 FY2026Mar 31, 2026-$12.11M–
Q4 FY2025Dec 31, 2025-$14.01M–
Q3 FY2025Sep 30, 2025-$11.76M–
Q2 FY2025Jun 30, 2025-$11.38M–
Q1 FY2025Mar 31, 2025-$12.49M–
Q4 FY2024Dec 31, 2024-$12.38M–
Q3 FY2024Sep 30, 2024-$11.69M–
Q2 FY2024Jun 30, 2024-$11.19M–
Q1 FY2024Mar 31, 2024-$10.79M–
Q4 FY2023Dec 31, 2023-$11.45M–
Q3 FY2023Sep 30, 2023-$11.13M–
Q2 FY2023Jun 30, 2023-$11.58M–
Q1 FY2023Mar 31, 2023-$14.32M–
Q4 FY2022Dec 31, 2022-$14.98M–
Q3 FY2022Sep 30, 2022-$14.38M–
Q2 FY2022Jun 30, 2022-$14.63M–
Q1 FY2022Mar 31, 2022-$12.27M–
Q4 FY2021Dec 31, 2021-$11.24M–
Q3 FY2021Sep 30, 2021-$6.51M–
Q2 FY2021Jun 30, 2021-$6.02M–
Q1 FY2021Mar 31, 2021-$3.65M–
Q4 FY2020Dec 31, 2020-$2.73M–
Q3 FY2020Sep 30, 2020-$2.02M–

More Lucid Diagnostics figures

See a number that looks wrong?